Skip to main content

and
  1. Article

    Open Access

    Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer

    Previous small-size studies reported BRAF-mutated NSCLC patients have comparable sensitivity to immune checkpoint inhibitors (ICIs). However, how BRAF mutation affects the tumor immune microenvironment (TIME) is ...

    Hui Li, Yongchang Zhang, Yanjun Xu, Zhiyu Huang, Guo** Cheng in Cell Death & Disease (2022)